In this Medtech Moment, Lindsey Dinneen breaks down what it really means to show up prepared—and why it's one of the easiest ways to add value.

Most medical device manufacturers start their consultation with me asking one of two questions: “Do we need a human factors validation study?” or “How should we do the study?” While important, neither ...

Arecor said the twiist's technology to measure each microdose—born out of inventor Dean Kamen's DEKA Research & Development—makes it ideal to deliver its ultra-concentrated insulin. (Sequel Med Tech) ...

As we stand at the precipice of a technological revolution in MedTech, it's clear that cross-sector collaboration will be the key driver of exponential growth. In my experience leading healthcare and ...

Medtech association AdvaMed went to Capitol Hill today to make the case that the medical device industry should be exempt from the global tariffs pursued by the Trump administration. AdvaMed’s ...

Sofinnova’s MD Start IV fund plans to support six to eight new medtech companies from the ‘ground-up’ over the next five years.

The National Defense Authorization Act needs to protect those who serve, including by ensuring the military can deliver safe, ...

Designing medical devices isn't enough. Medtech needs to design the patient experience surrounding those devices.

Continued focus on digital tuck-in acquisitions in Medtech M&A The challenging macroenvironment, marked by funding challenges, valuation declines and a near-shut IPO market, raised expectations for ...

Private equity is putting more money into MedTech, but that capital is concentrating around fewer, bigger deals in faster-growing categories. In ...

Veri MedTech is eight amendments deep on its S-1, now locking in 3.75 million shares for a $15 million Nasdaq listing with ...